Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2004 | 12-2003 | |
| Cash Flows From Operating Activities | ||
| Net Income | -16,535 | -19,005 |
| Depreciation Amortization | 1,750 | 2,630 |
| Accounts payable and accrued liabilities | 258 | 489 |
| Other Working Capital | 8,543 | 4,460 |
| Other Operating Activity | 23 | -453 |
| Operating Cash Flow | $-5,961 | $-11,879 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -788 | -1,667 |
| Purchase Of Investment | -24,279 | -36,894 |
| Sale Of Investment | 18,004 | 44,311 |
| Investing Cash Flow | $-7,063 | $5,750 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 1,970 | 3,015 |
| Debt Repayment | -1,855 | -2,794 |
| Common Stock Issued | 303 | 67 |
| Other Financing Activity | 13,991 | 0 |
| Financing Cash Flow | $14,410 | $288 |
| Beginning Cash Position | 10,478 | 16,318 |
| End Cash Position | 11,863 | 10,478 |
| Net Cash Flow | $1,385 | $-5,841 |
| Free Cash Flow | ||
| Operating Cash Flow | -5,961 | -11,879 |
| Capital Expenditure | -788 | -1,667 |
| Free Cash Flow | -6,750 | -13,546 |